Newcells Biotech Ltd

Were here to accelerate your therapys journey through the complexities of drug discovery and development. Putting innovation at the forefront of our capabilities, industry-leading experts help you confidently and proactively answer critical questions around the safety and efficacy of your product with our gold-standard in vitro models. By harnessing the power of predictive data, we navigate this crucial step efficiently and cost-effectively to maximise the potential of your therapy achieving clinical and market success. By combining our unique expertise with cutting-edge technologies, weve created predictive in vitro models that offer targeted solutions to your complex problems. Our tissue model platforms,...

Induced pluripotent stem cells (ipscs),cellular reprogramming and differentiation,supply of ipsc derived cells for drug development,sourcing samples for human disease cell lines,nephrotoxity testing,admet,diki,drug transport studies,rpe,retinal epithelia,lung epithelia,proximal tubule model,stem cell models,drug induced kidney injury (diki),disease modelling,retinal epithelial model,toxicity,retina,kidney,and lung

Newcells biotech ltd operates in the Research services industry.

Newcells biotech ltd's revenue is 11m - 100m

Newcells biotech ltd has 11 - 50 employees.